Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration

European Journal of Pharmacology

Volumn 364, Issue 2-3, 1999, Pages 79-87

  King, George R ^a   Xiong, Zhiping ^a   Ellinwood, Everett H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

5 HT3 receptor; Cocaine, continuous; Dopamine release; Nucleus accumbens; Rat; Tolerance

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; CALCIUM; COCAINE; ONDANSETRON; SEROTONIN 3 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN SLICE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALYSIS OF VARIANCE; ANIMALS; BIGUANIDES; BRAIN; CALCIUM; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; INFUSION PUMPS; INJECTIONS, SUBCUTANEOUS; MALE; ONDANSETRON; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0032923997     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00795-X     Document Type: Article

References (30)

1. Benuck M., Reith M.E.A. Dopamine releasing effect of phenylbiguanide in rat striatal slices. Naunyn-Schmeideberg's Arch. Pharmacol. 345:1992;666-672.
2. Blake J.C., Palmer J.L., Minton N.A., Burroughs A.K. The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment. Br. J. Clin. Pharmacol. 35:1993;441-443.
3. 3 receptor releases dopamine from striatal slice. Eur. J. Pharmacol. 40:1988;548.
4. 3 receptors in rat striatum. J. Pharmacol. Exp. Ther. 251:1989;803-809.
5. Campbell A.D., McBride W.J. Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens. Pharmacol. Biochem. Behav. 51:1995;835-842.
6. 3 receptor agonist 1-(m-chlorophenyl)-biguanide interacts with the dopamine transporter in rat brain synaptosomes. Euro. J. Pharmacol. 290:1995;157-162.
7. Carroll M.E., Lac S.T., Asencio M., Kragh R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35:1990;237-244.
8. Carroll M.E., Lac S.T., Asencio M., Kragh R. Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan. Psychopharmacology. 100:1990;293-300.
9. 10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine. J. Pharmacol. Exp. Ther. 287:1993;1445-1453.
10. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res. 543:1991;354-357.
11. Costall B., Naylor R.J. Extrapyramidal and mesolimbic involvement with the stereotypic activity of D- and L-amphetamine. Eur. J. Pharmacol. 25:1974;121-129.
12. 3 receptor antagonist GR38302F on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br. J. Pharmacol. 92:1987;881-890.
13. 3 receptor agonists and antagonists for alteration of aversive behavior in mice. Br. J. Pharmacol. 96:1989;325-332.
14. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Onaivi E.S., Tyers M.B. Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacol. Biochem. Behav. 36:1990;339-344.
15. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Onaivi E.S., Tyers M.B. Sites of action of Ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol. Biochem. Behav. 36:1990;339-344.
16. Cunningham K.A., Lakoski J.M. Electrophysiological effects of cocaine and procaine on dorsal raphe serotonin neurons. Eur. J. Pharmacol. 148:1988;457-462.
17. Cunningham K.A., Lakoski J.M. The interaction of cocaine with serotonin dorsal raphe neurons: single-unit extracellular recording studies. Neuropsychopharmacology. 3:1990;41-50.
18. Cunningham K.A., Asprodini E.K., Bernau N.A., Richard C.A., Lakoski J.M. Enhanced inhibitory responses of serotonin neurons in the dorsal raphe nucleus (DRN) after repeated cocaine exposure. Soc. Neurosci. Abstr. 13:1987;1651. (part 3).
19. Cunningham K.A., Paris J.M., Goeders N.E. Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse. 11:1992;112-123.
20. 3 receptors in drug dependence. Drug Alcohol Depend. 38:1995;155-171.
21. Joyner C., King G., Lee T.H., Ellinwood E.H. A technique for the continuous infusion of high doses of cocaine by osmotic minipump. Pharmacol. Biochem. Behav. 44:1993;971-973.
22. King G.R., Joyner C., Lee T., Kuhn C., Ellinwood E.H. Intermittent and continuous cocaine administration: residual behavioral states during withdrawal. Pharmacol. Biochem. Behav. 43:1992;243-248.
23. King G.R., Kuhn C., Ellinwood E.H. Dopamine efflux during withdrawal from continuous or intermittent cocaine. Psychopharmacology. 111:1993;179-184.
24. 3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine. Pharmacol. Biochem. Behav. 47:1994;399-407.
25. 3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration. Psychopharmacology. 117:1995;458-465.
26. 3 receptor antagonist, and cocaine. Psychopharmacology. 130:1997;159-165.
27. 3 agonist induced DA release in the nucleus accumbens during withdrawal from continuous cocaine administration. Psychopharmacology. 130:1997;242-248.
28. Reith M.E.A., Benuck M., Lajtha A. Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J. Pharmacol. Exp. Ther. 243:1987;281-287.
29. Roila F., Delfavero A. Ondansetron clinical pharmacokinetics. Clin. Pharmacokinet. 29:1995;95-109.
30. 3 receptor antagonists on cocaine-induced sensitization. Poster presented at the 36th annual meeting of the American College of Neuropsychopharmacology. Waikoloa, HI.